Abstract
The development of predictive biomarkers is a multifactorial laboratory exercise. In this chapter, we address some of these determinants: the pre-analytical factors that may influence downstream molecular tests; the types of sample and the essential use of the morphomolecular aspects in order to evaluate tumors as part of analytical variable management; the use of biorepositories; and the choice of most appropriate technologies for predictive biomarker medicine. Together, these represent the laboratory milieu that requires management for the successful analysis, and effective delivery of a predictive biomarker, from sample collection to test interpretation, including the potential for circulating tumor, cell-free DNA as a biomarker of discovery or profiling. We emphasize the need for effective and robust validation of tests and the recording of clear and concise management throughout the process of biomarker development. In doing so, we propose that morphological analysis remains the cornerstone of tissue-based diagnostics, and we propose a morphomolecular paradigm to modern pathology and modern diagnostics in the era of molecular medicine.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Yildiz-Aktas IZ, Dabbs DJ, Cooper KL, Chivukula M, McManus K, Bhargava R. The effect of 96-hour formalin fixation on the immunohistochemical evaluation of estrogen receptor, progesterone receptor, and Her2 expression in invasive breast carcinoma. Am J Clin Pathol. 2012;137:691–8.
Babic A, Loftin IR, Stanislaw S, Wang M, Miller R, Warren SM, et al. Methods. 2010;52:287–300.
Pang B, Dettmer M, Ong CW, Dhewar AN, Gupta S, Lim GL, et al. The positive impact of cytological specimens for EGFR mutation testing in non-small cell lung cancer: a single South East Asian Laboratory’s analysis of 670 cases. Cytopathology. 2012;23:229–36.
Mattocks CJ, Morris MA, Mathijs G, Swinnen E, Corveleyn A, Dequeker E, et al. A standardized framework for the validation and verification of clinical molecular genetic tests. Eur J Hum Genet. 2010;18:1276–88.
Maxwell P, Salto-Tellez M. Validation of immunocytochemistry as a morphological technique. Cancer Cytopathol. 2016;124:540–5.
Lewis C, McQuaid S, Hamilton PW, Salto-Tellez M, McArt D, James JA. Building a “repository of science”: the importance of integrating biobanks within molecular pathology programmes. Eur J Cancer. 2016;67:191–9.
McCourt CM, Boyle D, James J, Salto-Tellez M. Immunohistochemistry in the era of personalised medicine. J Clin Pathol. 2013;66:58–61.
Hynes S, Pang B, james J, Maxwell P, Salto-Tellez M. Tissue-based next generation sequencing: application in a universal healthcare system. Br J Cancer. 2017;116:553–60.
Salto Tellez M, Gonzalez de Castro D. Next-generation sequencing: a change in paradigm in molecular diagnostic validation. J Pathol. 2014;234:5–10.
Wong SQ, Li J, AY-C T. Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing. BMC Med Genet. 2014;7:23–33.
Tan SP, Natrajan R, Reis-Filho JS. Microarray-based comparative genomic hybridization. In: Hannon-Fletcher M, Maxwell P, editors. Advanced techniques in diagnostic cellular pathology. Oxford: Wiley-Blackwell; 2009.
Turajlic S, Swanton C. Metastasis as an evolutionary process. Science. 2016;352:169–75.
Geiss GK, Bumgarner RE, Birditt B, et al. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol. 2008;26:317–25.
Hindson CM, Chevillet JR, Briggs HA, et al. Absolute quantification by droplet digital PCR versus analog real-time PCR. Nat Methods. 2013;10:1003–5.
Brown SD, Warren RL, Gibb EA, et al. Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival. Genome Res. 2014;24:743–50.
Salto-Tellez M. A case for integrated morphomolecular diagnostic pathologists. Clin Chem. 2007;53:1188–90.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Maxwell, P., Salto-Tellez, M. (2019). Overview of Methods Used in Predictive Biomarker Studies in a Molecular Anatomic Pathology Laboratory. In: Badve, S., Kumar, G. (eds) Predictive Biomarkers in Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-95228-4_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-95228-4_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-95227-7
Online ISBN: 978-3-319-95228-4
eBook Packages: MedicineMedicine (R0)